| 2024-01-02 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 11,044 0.0112% | $131.47 | $1.45M | +4.1% | |
| 2023-05-01 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 4,300 0.0043% | $101.43 | $436,135 | +9.01% | |
| 2023-04-21 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 6,034 0.0063% | $105.04 | $633,787 | +7.95% | |
| 2023-04-19 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 903 0.0009% | $105.00 | $94,819 | +7.22% | |
| 2022-04-01 | Sale | Neurocrine Biosciences, Inc. NBIX | 10,728 0.0111% | $94.93 | $1.02M | +8.11% | ||
| 2019-05-07 | Regulus Therapeutics Inc. RGLS | director | 92,889 0.5004% | $1.08 | $100,320 | -40% | ||
| 2018-01-24 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 9,500 0.0108% | $90.00 | $855,000 | +4.72% | |
| 2017-07-25 | Regulus Therapeutics Inc. RGLS | director | 274,725 0.2501% | $0.91 | $250,000 | -17.12% | ||
| 2017-03-07 | Regulus Therapeutics Inc. RGLS | director | 250,000 0.4718% | $1.15 | $287,500 | +2.61% | ||
| 2017-02-01 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 10,750 0.0122% | $42.28 | $454,510 | +25.91% | |
| 2016-11-23 | Fate Therapeutics, Inc. FATE | director | 751,878 1.6334% | $2.66 | $2M | +11.55% | ||
| 2015-07-21 | Regulus Therapeutics Inc. RGLS | director | 61,235 0.1176% | $10.19 | $624,199 | -33.01% | ||
| 2015-07-20 | Regulus Therapeutics Inc. RGLS | director | 38,765 0.0726% | $10.13 | $392,779 | -34.13% | ||
| 2015-01-20 | Sale | Illumina, Inc. ILMN | director | 16,000 0.0107% | $188.99 | $3.02M | -1.83% | |
| 2014-09-29 | Sale | Illumina, Inc. ILMN | director | 248 0.0002% | $163.73 | $40,605 | +17.21% | |
| 2014-06-30 | Sale | Illumina, Inc. ILMN | director | 334 0.0002% | $174.34 | $58,230 | +5.39% | |
| 2014-04-21 | Sale | Illumina, Inc. ILMN | director | 879 0.0006% | $135.82 | $119,386 | +27.7% | |
| 2014-04-15 | Daré Bioscience, Inc. DARE | director | 37,738 0.2385% | $7.00 | $264,166 | -11.59% | ||
| 2014-03-31 | Sale | Illumina, Inc. ILMN | director | 296 0.0002% | $143.50 | $42,476 | +19.65% | |
| 2014-02-03 | Sale | Illumina, Inc. ILMN | director | 8,551 0.0067% | $151.93 | $1.3M | +13.48% |